Contrarius Group Holdings LTD Intellia Therapeutics, Inc. Transaction History
Contrarius Group Holdings LTD
- $1.63 Trillion
- Q4 2024
A detailed history of Contrarius Group Holdings LTD transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Contrarius Group Holdings LTD holds 1,011,863 shares of NTLA stock, worth $9.69 Million. This represents 0.72% of its overall portfolio holdings.
Number of Shares
1,011,863Holding current value
$9.69 Million% of portfolio
0.72%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
324Shares Held
91.4MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$120 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$97.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$91.9 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$49.3 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$47.4 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $728M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...